Spatial Dissection of the Distinct Cellular Responses to Normal Aging and Alzheimer's Disease in Human Prefrontal
Yun Gong1, Mohammad Haeri2, Xiao Zhang1
1Tulane Center for Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, LA, 70112, USA.
Aging and Alzheimer's disease (AD) alter the human prefrontal cortex. This study reveals spatial transcriptomic changes, identifying ZNF460 as a potential therapeutic target for AD by improving cellular defense mechanisms.
Area of Science:
- Neuroscience
- Genomics
- Aging Research
Background:
- Aging increases Alzheimer's disease (AD) risk, exacerbating pathologies like amyloid-β (Aβ), inflammation, and oxidative stress.
- The human prefrontal cortex (PFC) is particularly vulnerable to aging and AD.
- Understanding molecular changes in the PFC is crucial for AD mechanisms and therapeutics.
Purpose of the Study:
- To create the first subcellular resolution spatial transcriptome atlas of the human PFC in normal aging (NA) and AD.
- To investigate molecular alterations across neocortical layers and cell-cell interactions during AD progression.
- To identify novel therapeutic targets for AD.
Main Methods:
- Utilized STOmics® Stereo-seq for spatial transcriptome profiling of human PFC from AD cases and controls.
- Analyzed transcriptional changes across six neocortical layers and layer-to-layer interactions.
- Performed cell-type specific gene co-expression analysis and identified regulatory factors.
Main Results:
- Revealed distinct transcriptional alterations and disrupted laminar architecture in AD PFC.
- Identified stress-responsive genes in neurons and non-neuronal cells, with diminished neuroprotective interactions in AD.
- Discovered three neuronal gene modules negatively correlated with AD progression and a novel regulator, ZNF460.
Conclusions:
- The developed spatial transcriptome atlas provides unprecedented insight into PFC molecular changes in AD.
- Diminished cellular defense and clearance mechanisms contribute to AD progression.
- ZNF460 represents a promising new therapeutic target for AD treatment.
More Related Videos
09:28Gentle Isolation of Nuclei from the Brain Tissue of Adult African Turquoise Killifish, a Naturally Short-Lived Model for Aging Research
Published on: August 9, 2022
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
